线粒体靶向抗氧化剂MitoQ对缺氧性肺动脉高压的影响
研究探讨线粒体靶向抗氧化剂MitoQ在急性和慢性缺氧条件下对缺氧性肺血管收缩(HPV)、慢性缺氧诱导的肺动脉高压及右心室重构的作用。在离体灌注小鼠肺中,MitoQ显著抑制急性HPV及急性缺氧诱导的超氧化物升高;慢性缺氧(10% O2,4周)下,MitoQ不影响肺动脉高压发展,但减轻慢性缺氧及肺动脉环扎后的右心室重构。提示肺动脉平滑肌细胞线粒体ROS介导急性HPV而非慢性缺氧性肺动脉高压,MitoQ可能对急性HPV增强状态有益。
要点
- MitoQ显著抑制离体小鼠肺急性缺氧(1% O2,10分钟)诱导的肺血管收缩。
- 慢性缺氧(10% O2,4周)下MitoQ未影响肺动脉高压发展,但减轻右心室重构。
- 肺动脉平滑肌细胞线粒体ROS介导急性HPV,但不介导慢性缺氧性肺动脉高压。
核心结论
- 肺动脉平滑肌细胞线粒体ROS增加介导急性缺氧性肺血管收缩,但不介导慢性缺氧诱导的肺动脉高压。
- MitoQ可能对急性缺氧性肺血管收缩增强的状态有益。
研究设计与样本
- 离体无血灌注小鼠肺用于急性HPV实验(1% O2,10分钟)。
- 小鼠暴露于慢性缺氧(10% O2,4周)或行肺动脉主干环扎术,分别给予MitoQ或癸基三苯基膦(50 mg·kg-1·day-1)处理。
主要发现
- 急性缺氧下肺动脉平滑肌细胞总细胞超氧化物和线粒体ROS水平升高,而肺成纤维细胞中降低。
- MitoQ显著抑制急性HPV及急性缺氧诱导的超氧化物浓度升高。
- 慢性缺氧后肺动脉平滑肌细胞ROS降低,而右心室ROS升高。
- MitoQ未影响慢性缺氧诱导的肺动脉高压发展,但减轻慢性缺氧后及肺动脉环扎后的右心室重构。
临床怎么用
- MitoQ可能适用于急性缺氧性肺血管收缩增强的临床情况,但慢性缺氧性肺动脉高压患者使用需谨慎评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Increased mitochondrial reactive oxygen species (ROS), particularly superoxide, have been suggested to mediate hypoxic pulmonary vasoconstriction (HPV), chronic hypoxia-induced pulmonary hypertension and right ventricular remodelling.We determined ROS in acute and chronic hypoxia, and investigated the effect of the mitochondria-targeted antioxidant MitoQ under these conditions.The effect of MitoQ or its inactive carrier substance, decyltriphenylphosphonium, on acute HPV (1% O2 for 10 min) was investigated in isolated blood-free perfused mouse lungs. Mice exposed to chronic hypoxia (10% O2 for 4 weeks) or after banding of the main pulmonary artery were treated with MitoQ or decyltriphenylphosphonium (50 mg·kg-1·day-1).Total cellular superoxide and mitochondrial ROS levels were increased in pulmonary artery smooth muscle cells but decreased in pulmonary fibroblasts in acute hypoxia. MitoQ significantly inhibited HPV and acute hypoxia-induced rise in superoxide concentration. ROS was decreased in pulmonary artery smooth muscle cells, while it increased in the right ventricle after chronic hypoxia. Correspondingly, MitoQ did not affect the development of chronic hypoxia-induced pulmonary hypertension but attenuated right ventricular remodelling after chronic hypoxia as well as after pulmonary arterial banding.Increased mitochondrial ROS of pulmonary artery smooth muscle cells mediate acute HPV, but not chronic hypoxia-induced pulmonary hypertension. MitoQ may be beneficial under conditions of exaggerated acute HPV.
引用
- Pak O, Scheibe S, Esfandiary A, et al. Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension. Eur Respir J. 2018. PMID: 29419444. doi:10.1183/13993003.01024-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。